oxazoles has been researched along with u 100480 in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Barbachyn, MR; Brickner, SJ; Cynamon, MH; Ford, CW; Glickman, SE; Grega, KC; Hendges, SK; Hutchinson, DK; Kilburn, JO; Klemens, SP; Toops, DS; Zurenko, GE | 1 |
Artico, M; Deidda, D; Lampis, G; Mai, A; Massa, S; Pompei, R; Sbardella, G | 1 |
Duncan, K | 1 |
Chase, S; Cynamon, MH; Klemens, SP; Sharpe, CA | 1 |
Chang, KC; Heyckendorf, J; Lange, C; Olaru, ID; von Groote-Bidlingmaier, F; Yew, WW | 1 |
Betoudji, F; Converse, PJ; Dartois, V; Li, SY; Mdluli, KE; Mendel, CM; Nuermberger, EL; Tasneen, R; Tyagi, S; Williams, K; Yang, T | 1 |
Causgrove, C; Dartois, V; Drusano, GL; Flynn, JL; Graham, E; Kim, S; Louie, A; Miranda Silva, C; Peloquin, CA; Scanga, CA; Schmidt, S; Stein, B; Zimmerman, M | 1 |
2 review(s) available for oxazoles and u 100480
Article | Year |
---|---|
The impact of genomics on the search for novel tuberculosis drugs.
Topics: Acetamides; Antitubercular Agents; Drug Design; Genome, Bacterial; Mycobacterium tuberculosis; Ofloxacin; Oxazoles; Rifamycins | 1998 |
Novel drugs against tuberculosis: a clinician's perspective.
Topics: Adamantane; Antitubercular Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diarylquinolines; Drug Therapy, Combination; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Female; Follow-Up Studies; Humans; Male; Nitroimidazoles; Oxazoles; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2015 |
5 other study(ies) available for oxazoles and u 100480
Article | Year |
---|---|
Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium tuberculosis; Oxazoles; Rats | 1996 |
N-[4-(1,1'-biphenyl)methyl]-4-(4-thiomorpholinylmethyl) benzenamines as non-oxazolidinone analogues of antimycobacterial U-100480.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium; Oxazoles; Species Specificity; Vero Cells | 1998 |
Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Antitubercular Agents; Female; Linezolid; Mice; Mycobacterium tuberculosis; Oxazoles; Oxazolidinones; Tuberculosis | 1999 |
Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis.
Topics: Animals; Antitubercular Agents; Bacterial Load; Diarylquinolines; Disease Models, Animal; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Linezolid; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nitroimidazoles; Organophosphates; Oxazoles; Oxazolidinones; Pyrazinamide; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |
Pharmacokinetics of tedizolid, sutezolid, and sutezolid-M1 in non-human primates.
Topics: Animals; Anti-Bacterial Agents; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Oxazolidinones; Primates; Tetrazoles | 2020 |